E‑News Updates

  • February 13, 2020
    Tags: 2021 Budget, biosimilars, bipartisan drug pricing effort, Chuck Grassley, Chuck Schumer, drug pricing, House Ways & Means, Mitch McConnell, surprise billing
  • January 28, 2020
    Tags: ACA, Alex Azar, drug pricing, healthcare polling data, international drug pricing plan, Jared Polis, Medicare Part D, medicare part D redesign, public-option insurance plan
  • January 23, 2020
    Tags: ACA, Andrew Cuomo, anti-competitive hospital, Chrstine Wilson, draft exchange rule setting, drug prices, Medicare Part D, medicare part D redesign
  • January 16, 2020
    Tags: ACA, Affordable Care Act unconstitutional, copay accumulator policy, drug prices tv ads, individual mandate, Judge Karen LeCraft Henderson, Leslie Rutledge, prescription drug reimbursement, regulate PBM
  • January 7, 2020
    Tags: Affordable Care Act unconstitutional, Alex Azar, Allyson Schwartz, biosimilar, Chuck Grassley, drug pricing bill, Nancy Pelosi, Nicholas Bagley, repeal health insurance tax, Xavier Becerra

e-News Archive

Roundtable Activity

  • August 6, 2019
    Tags: congress, drug pricing
    Given the amount of recent legislative and regulatory activity regarding a variety of issues relative to drug pricing, the Roundtable presented a webinar for members and friends on Tuesday, August 6th. The upcoming Congressional summer recess provides an opportunity for us to step back and review recent legislative and regulatory activity regarding critical Roundtable priorities. […]
  • July 19, 2019
    Tags: Andrew MacPherson, Cadillac Tax, Chuck Schumer, Mitch McConnell, repeal
    On behalf of millions of public sector workers and their families, the Public Sector HealthCare Roundtable has addressed a letter to Senate Majority Leader Mitch McConnell (R-KY) and Senate Minority Democratic Leader Charles Schumer (D-NY) urging the U. S. Senate to provide relief from the 40 percent excise tax on health benefits, known as the […]

Activity Archive